Dysregulated BACE1-mediated APP processing for β-CTF/Aβ overproduction and related pathologies under deficient CNS insulin signaling on diabetic/obese conditions may be linked to AD progression in an early preclinical stage. The gene discussed is INS; the disease is Alzheimer disease.